Find clinical trials for Kidney Disease in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Kidney Disease trials near Cincinnati, OH, USA:
This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...
Phase 3
Cincinnati, Ohio, United States and 43 other locations
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
Cincinnati, Ohio, United States and 62 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Cincinnati, Ohio, United States and 330 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Cincinnati, Ohio, United States and 94 other locations
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compare...
Phase 3
Cincinnati, Ohio, United States and 711 other locations
To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD
Phase 3
Cincinnati, Ohio, United States and 22 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Cincinnati, Ohio, United States and 758 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Cincinnati, Ohio, United States and 134 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Cincinnati, Ohio, United States and 151 other locations
A Phase III, single-arm, multicenter pediatric clinical study evaluating atrasentan in children and adolescents aged 2 to \<18 years with primary imm...
Phase 3
Cincinnati, Ohio, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal